Chu Hao

Sep 11, 2023 | onlinelibrary.wiley.com | Lu Tian |Surui Yao |Chu Hao |Yuyang Feng

1 INTRODUCTION Gastric cancer (GC) is one of the most malignant carcinomas and the fourth leading cause of cancer-related death worldwide, and it is estimated that approximately over 1 million new GC cases emerged in 2020.1 GC is a highly heterogenetic disease with a poor prognosis, and its molecular mechanism is not well understood.2 Consequently, continuous efforts are needed to clarify its molecular mechanisms and determine new therapeutic targets for GC.